We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Bile Enables Norovirus to Grow in Laboratory Cell Cultures

By LabMedica International staff writers
Posted on 07 Sep 2016
Bile proved to be the key to the first successful growth of norovirus in laboratory cell cultures.

Noroviruses (NoVs) are a leading cause of gastroenteritis globally, yet the host factors required for NoV infection are poorly understood. More...
Human norovirus will not infect any of the species typically used in biomedical research, such as mice, rats, or rabbits nor will it grow in human cell cultures.

After the failure of many previous attempts to cultivate norovirus in cell cultures, investigators at Baylor College of Medicine (Houston, TX, USA) turned to a recently developed human intestinal epithelial cell culture system that included enterocytes. These novel, multi-cellular human cultures, called enteroids, were made from adult intestinal stem cells from patient tissues.

The investigators reported in the August 25, 2016, online edition of the journal Science that novel cell culture system not withstanding, the method was not impressively successful until they added bile, a critical factor of the intestinal milieu. With the addition of bile, the culture system recapitulated the human intestinal epithelium, permitting human host-pathogen studies of previously non-cultivatable pathogens, and allowed the assessment of methods to prevent and treat human NoV infections.

"When we added bile to the cultures, norovirus strains that did not grow before now grew in large numbers," said senior author Dr. Mary Estes, professor of human and molecular virology and microbiology at Baylor College of Medicine. "People have been trying to grow norovirus in the lab for a very long time. We tried for the last 20 years. Despite all the attempts and the success of growing other viruses, it remained a mystery why noroviruses were so hard to work with. We were able to grow norovirus in cultures that mimic the intestinal environment, where the virus naturally grows, by adding bile to the cultures. Bile is critical for several important bacterial pathogens, but this is the first time it has been shown that bile is important for the replication of human intestinal viruses."

Related Links:
Baylor College of Medicine



Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Silver Member
PCR Plates
Diamond Shell PCR Plates
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.